학술논문

Long-Term Effects of Gene Therapy in a Novel Mouse Model of Human MFRP-Associated Retinopathy
Document Type
article
Source
Human Gene Therapy. 30(5)
Subject
Biomedical and Clinical Sciences
Ophthalmology and Optometry
Genetics
Neurosciences
Gene Therapy
Neurodegenerative
Eye Disease and Disorders of Vision
Aetiology
2.1 Biological and endogenous factors
Eye
Animals
Biomarkers
Dependovirus
Disease Models
Animal
Electroretinography
Genetic Predisposition to Disease
Genetic Therapy
Genetic Vectors
Humans
Immunohistochemistry
Membrane Proteins
Mice
Mice
Knockout
Phenotype
Retinal Diseases
Retinal Pigment Epithelium
Tomography
Optical Coherence
Gene therapy
MFRP mouse model
retinal degeneration
RPE
AAV
Immunology
Medical biotechnology
Language
Abstract
Patients harboring homozygous c.498_499insC mutations in MFRP demonstrate hyperopia, microphthalmia, retinitis pigmentosa, retinal pigment epithelial atrophy, variable degrees of foveal edema, and optic disc drusen. The disease phenotype is variable, however, with some patients maintaining good central vision and cone function till late in the disease. A knock-in mouse model with the c.498_499insC mutation in Mfrp (Mfrp KI/KI) was developed to understand the effects of these mutations in the retina. The model shares many of the features of human clinical disease, including reduced axial length, hyperopia, retinal degeneration, retinal pigment epithelial atrophy, and decreased electrophysiological responses. In addition, the eyes of these mice had a significantly greater refractive error (p